-
公开(公告)号:EP1086101B1
公开(公告)日:2002-12-18
申请号:EP99928479.7
申请日:1999-06-08
发明人: THURIEAU, Christophe, Alain , POITOUT, Lydie, Francine , GALCERA, Marie-Odile , MOINET, Christophe, Philippe , GORDON, Thomas, D. , MORGAN, Barry, A. , BIGG, Dennis, C., H. , POMMIER, Jacques
IPC分类号: C07D471/04 , A61K31/44 , C07D471/20 , C07D471/10 , C07D495/04
CPC分类号: C07D471/04 , C07D471/10 , C07D495/04
摘要: The present invention is directed to compounds of formula (I) wherein the variables are defined in the specification, which bind to somatostatin receptors and block Na channels.
-
公开(公告)号:EP0904274B1
公开(公告)日:2005-05-25
申请号:EP97907717.9
申请日:1997-02-14
IPC分类号: C07D487/04 , C07D277/20 , C07D277/28 , C07D277/38 , C07D263/30 , C07D263/34 , C07D233/54 , A61K31/495 , A61K31/425 , A61K31/42 , A61K31/415
CPC分类号: C07D233/64 , C07D277/28 , C07D277/56 , C07D487/04
摘要: A family of compounds capable of inhibiting the activity of farnesyl transferase.
-
3.
公开(公告)号:EP1086086B1
公开(公告)日:2004-10-13
申请号:EP99927323.8
申请日:1999-06-08
发明人: THURIEAU, Christophe, Alain , POITOUT, Lydie, Francine , GALCERA, Marie-Odile , GORDON, Thomas, D. , MORGAN, Barry , MOINET, Christophe, Philippe
IPC分类号: C07D233/00
CPC分类号: C07D233/64 , C07D401/14 , C07D403/06 , C07D403/14 , C07D405/14 , C07D409/14 , C07D471/04 , C07D471/10 , C07D487/04 , C07D491/14
摘要: The present invention is directed to imidazolyl derivatives of formula (I) where the substituents are defined in the specification, which are useful as agonists or antagonists of somatostatin receptors.
-
公开(公告)号:EP1140942B1
公开(公告)日:2004-03-10
申请号:EP99968984.7
申请日:1999-12-30
IPC分类号: C07D487/04 , A61K31/4985 , A61K31/551 , A61K31/5517 , A61P35/00 , C07D513/14 , C07D519/00
CPC分类号: C07D487/04 , C07D513/14
摘要: A family of imidazole compounds useful for inhibiting the activity of prenyl transferases. The compounds are covered by formula (I): wherein X is (CHR11)n3(CH2)n4Z(CH2)n5 where Z is O, N(R12), S, or a bond; Y is CO, CH¿2?, CS, or a bond; R?1¿ is A, B, C, D, E, F, G, H, I, J or N(R24R25); and the remaining substituents are as defined in the disclosure.
-
-
-